Instituto Rosenbusch S.A. (BCBA:ROSE)

Revenue by Segment

Financials in millions ARS. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Biological Products	2.31B	5.97B	5.96B	2.03B	821.71M
Biological Products Growth	-61.37%	0.19%	193.67%	147.05%	80.56%
Pharmaceutical products	3.13B	4.61B	3.72B	2.01B	638.44M
Pharmaceutical products Growth	-32.06%	23.84%	85.32%	214.84%	80.56%
Other Items	165.11M	299.73M	174.06M	235.76M	62.37M
Other Items Growth	-44.91%	72.19%	-26.17%	278.01%	80.56%
Total	5.61B	10.89B	9.86B	4.28B	1.52B
Total Growth	-48.50%	10.40%	130.61%	180.84%	80.56%

Revenue by Geography

Financials in millions ARS. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Argentina	4.09B	8.45B	8.92B	3.56B	1.32B
Argentina Growth	-51.58%	-5.23%	150.70%	168.79%	73.30%
Foreign	2.31B	2.44B	944.42M	719.37M	199.37M
Foreign Growth	-5.08%	157.93%	31.28%	260.82%	150.19%
Total	6.40B	10.89B	9.86B	4.28B	1.52B
Total Growth	-41.17%	10.40%	130.61%	180.84%	80.56%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 12, 2026

Data Sources Report a data error